Responding to restrictive formularies

Psychiatric Annals

Volumn 34, Issue 2, 2004, Pages 139-148

  Tennison Jr , Clifton R ^a,b  

^a Helen Ross McNabb Center   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEW DRUG;

COST EFFECTIVENESS ANALYSIS; DRUG COST; DRUG FORMULARY; HEALTH CARE COST; HEALTH CARE SYSTEM; HEALTH MAINTENANCE ORGANIZATION; HUMAN; MANDATORY PROGRAM; MEDICAID; MEDICAL DECISION MAKING; MEDICAL SOCIETY; MENTAL DISEASE; MENTAL HEALTH SERVICE; PHARMACIST; PHARMACY BENEFIT MANAGER; PHYSICIAN ATTITUDE; PRACTICE GUIDELINE; REVIEW;

EID: 2042510994     PISSN: 00485713     EISSN: None     Source Type: Journal    
DOI: 10.3928/0048-5713-20040201-11     Document Type: Review

References (35)

1. American Psychiatric Association. NMHA Speaks Out Against Restricted Formularies. Psychiatr News. 1998;33(11):42.
2. Klein R, Day P, Redmayne S. Managing Scarcity. Buckingham, England: Open University Press; 1998.
3. Thase ME. Comparing the methods used to compare antidepressants. Psychopharmacol Bull. 2002;36(Suppl 1):4-17.
4. Carr-Hill R. Welcome? To the brave new world of evidence based medicine. Soc Sci Med. 1995;41(11):1467-1468.
5. National Mental Health Association. NMHA Policy Positions on Restrictive Formularies - Revised. Alexandria, Va: NMHA; 1998.
6. NMHA. Penny-wise and Pound Foolish: Restricting Access to Psychotropic Medications. Alexandria, Va: NMHA; 1998.
7. American Psychiatric Association. The Principles of Medical Ethics With Annotations Especially Applicable to Psychiatry. Washington, DC: APA; 2001.
8. Williams A. Cost-effectiveness analysis: is it ethical? J Med Ethics. 1992;18(1):7-11.
9. Dyer AR. Ethics and Psychiatry: Toward Professional Definition. Washington DC: American Psychiatric Press; 1988:1-40.
10. Moffic HS. The Ethical Way. San Francisco, Calif: Jossey-Bass Publishers; 1997:153.
11. Klein R. Can we restrict the health care menu? Health Policy. 1994;27(2):103-112.
12. Mental Health Associations of TN, NMHA, NAMI-TN, et al. Position on the Restrictive Formulary for TennCare Recipients. Nashville, Tenn: 1996.
13. Aaron HJ, Schwartz WB. The Painful Prescription. Washington, DC: The Brookings Institution; 1984.
14. American Association of Community Psychiatrists. Principles for formulary management in public sector managed care. Community Psychiatrist. 1996;10(2):5.
15. Principles for Systems of Managed Care. Washington, DC: US Dept. of Health and Human Services, Substance Abuse and Mental Health Services Administration, Center for Mental Health Services; 1996. Publication MC96-61.
16. Guidelines for Physician/Patient Relationships in the Managed Care Environment. Nashville, Tenn: State Volunteer Mutual Insurance Company; 1997.
17. APA. Position Statement: Restrictive Formularies and Therapeutic Drug Substitutions. Washington, DC: APA; 1997. Ref No. 970019.
18. American Society of Health-System Pharmacists. Principles of a sound drug formulary system. In: Formulary Management (Medication-Use Policy Development), Best Practices for Health-System Pharmacy, Positions and Practice Standards of ASHP 2001-2002. Bethesda, Md: American Society of Health- System Pharmacists; 2002.
19. California Psychiatric Association. Policy Regarding Medication Formularies. Sacramento, Calif: California Psychiatric Association; 1997.
20. APA. Position Statement: Psychiatric Pharmaceutical Carve-Outs. Washington, DC: APA; 1997. Ref No. 970018.
21. APA. Position Statement: Atypical Antipsychotic Medications. Washington DC: APA; 2000. Ref No. 200007.
22. American Society of Consultant Pharmacists. ASCP Policy Statement on Medication Formulary Principles for Older Adults. Alexandria, Va: American Society of Consultant Pharmacists; 2001.
23. American Academy of Child and Adolescent Psychiatry. Policy Statement. Restrictions on the Prescribing Practices of Child and Adolescent Psychiatrists by Managed Care Formularies. Washington, DC: American Academy of Child and Adolescent Psychiatry; 1997.
24. Somers S, Perkins J; National Health Law Program Inc. Model Prescription Drug Prior Authorization Process for State Medicaid Programs. Washington, DC: The Henry J. Kaiser Family Foundation; 2003:22.
25. Richardson SK. Letter from the director of the Center for Medicaid and State Operations to State Medicaid Directors; Februray 12, 1998. In: HCFA Provides State Medicaid Office with Guidance on Access to Atypical Antipsychotic Medication. Available at: http://www.nami.org/Content/Content- Groups/E News/19982/February_19982/ HCFA_Provides_State_Medicaid_Office_with_Guidance_on_Access_to Atypical_Antipsychotic_Medication.htm. Accessed December 15, 2003.
26. Hyman SE. Letter from the director of NIMH to the director of the Center for Medicaid and State Operations; January 16, 1998). In: HCFA Provides State Medicaid Office with Guidance on Access to Atypical Antipsychotic Medication. Available at: http://www.nami.org/Content/ContentGroups/E-News/19982/ February_19982/ HCFA_Provides_State_ Medicaid_Office_with _Guidance_on_Access_toAtypical_Antipsychotic_Medication. htm. Accessed December 15, 2003.
27. Albert T. Formularies Criticized as States Cut Medicaid Drug Costs. American Medical News; April 1, 2002. Available at: http://www.ama-assn.org/ amed-news/2002/04/01/gvsd0401.htm. Accessed December 15, 2003.
28. Florida Leads Pack of States Eyeing Formularies. Mental Health Weekly. 2001;11(33):1,4-5.
29. American Medical Association. Ethical opinions/guidelines. gifts to physicians from industry. In: Current Opinions of the Council on Ethical and Judicial Affairs. Code of Medical Ethics. Chicago, Ill: AMA; 2001.
30. Pharmaceutical Research and Manufacturers of America. PhRMA Code on Interactions with Healthcare Professionals. Washington, DC: Pharmaceutical Research and Manufacturers of America; 2002.
31. AMA. Ethical opinions/guidelines. Clarification of gifts to physicians from industry. In: Current Opinions of the Council on Ethical and Judicial Affairs. Code of Medical Ethics. Chicago, Ill: AMA; 2001.
32. AMA. Ethical opinions/guidelines. Continuing medical education. In: Current Opinions of the Council on Ethical and Judicial Affairs. Code of Medical Ethics. Chicago, Ill: AMA; 2001.
33. American Association for Emergency Psychiatry. Policy Regarding Research and Educational Project Support from Corporate Donors. Redmond, Wash: American Association for Emergency Psychiatry; 2001.
34. APA Ethics Committee. Standards for Commercial Support of Continuing Medical Education. Ethics Newsletter. 1992;8(2).
35. Casimir KC. Pharmaceutical Industry Sponsorship: Guidelines for Ethical Practice. Psychiatric Administrator. 2001;1(2):44-48.